222 related articles for article (PubMed ID: 21772113)
1. FOLFOX plus cetuximab for a patient with metastatic colorectal cancer with icterus due to multiple liver metastases.
Mizota A; Shitara K; Kondo C; Nomura M; Yokota T; Takahari D; Ura T; Muro K
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1205-8. PubMed ID: 21772113
[TBL] [Abstract][Full Text] [Related]
2. [A case of metastatic colorectal cancer with icterus due to multiple liver metastases treated effectively by FOLFOX plus bevacizumab].
Terasawa T; Koja S; Yasuda K; Fukuda K
Gan To Kagaku Ryoho; 2013 Aug; 40(8):1115-8. PubMed ID: 23986063
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
Asseburg C; Frank M; Köhne CH; Hartmann JT; Griebsch I; Mohr A; Osowski U; Schulten J; Mittendorf T
Clin Ther; 2011 Apr; 33(4):482-97. PubMed ID: 21635994
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of metastatic colorectal cancer.
Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
[TBL] [Abstract][Full Text] [Related]
5. [A successful treatment of conversion chemotherapy by mFOLFOX6 plus cetuximab for initially unresectable synchronous colorectal liver metastases].
Yoshidome H; Kimura F; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Takeuchi D; Takayashiki T; Suda K; Kuboki S; Miyazaki M
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1853-6. PubMed ID: 22083196
[TBL] [Abstract][Full Text] [Related]
6. [Successful treatment of advanced sigmoid colon cancer with liver metastases with cetuximab monotherapy as first-line treatment-a case report].
Harada K; Hatanaka K; Kinoshita K; Kawamoto Y; Yamato H; Ogawa K; Yamamoto Y; Naruse H
Gan To Kagaku Ryoho; 2014 Jul; 41(7):897-900. PubMed ID: 25131880
[TBL] [Abstract][Full Text] [Related]
7. The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer.
Malik Z; Eng C
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):4-7. PubMed ID: 17491584
[No Abstract] [Full Text] [Related]
8. Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer.
Tabernero J; Van Cutsem E; Díaz-Rubio E; Cervantes A; Humblet Y; André T; Van Laethem JL; Soulié P; Casado E; Verslype C; Valera JS; Tortora G; Ciardiello F; Kisker O; de Gramont A
J Clin Oncol; 2007 Nov; 25(33):5225-32. PubMed ID: 18024868
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of bolus 5-fluorouracil for recurrent or metastatic colorectal cancer treated with FOLFOX+ BevacizumabTherapy].
Yoshida Y; Hasegawa J; Nishimura J; Hirota M; Kim Y; Nezu R
Gan To Kagaku Ryoho; 2011 Aug; 38(8):1293-6. PubMed ID: 21829066
[TBL] [Abstract][Full Text] [Related]
10. [Cetuximab-associated skin ulceration in patient with metastatic colorectal cancer: a case report].
Tsuboi K; Kawase Y; Okochi O; Hattori M; Takami Y; Takeda S; Mizuno A; Sato Y; Uno Y; Hayashi T; Sasada Y; Takamura S; Kozaki K
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1549-52. PubMed ID: 21918361
[TBL] [Abstract][Full Text] [Related]
11. [Two cases of interstitial pneumonia caused by cetuximab plus mFOLFOX6 therapy in metastatic colorectal cancer patients].
Shioiri M; Hasegawa M; Tanaka H; Toura I; Kudo S; Sato K; Inoue K; Nakanishi T; Nishiyama S; Takebe S; Ogino Y; Ohsaki S; Nagashima Y
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2198-200. PubMed ID: 23268022
[TBL] [Abstract][Full Text] [Related]
12. Conversion chemotherapy using cetuximab plus FOLFIRI followed by bevacizumab plus mFOLFOX6 in patients with unresectable liver metastases from colorectal cancer.
Uehara K; Ishiguro S; Hiramatsu K; Nishio H; Takeuchi E; Takahari D; Yoshioka Y; Takahashi Y; Ebata T; Yoshimura K; Muro K; Nagino M
Jpn J Clin Oncol; 2011 Oct; 41(10):1229-32. PubMed ID: 21840871
[TBL] [Abstract][Full Text] [Related]
13. [A case of metastatic rectal cancer in an extremely aged patient successfully treated with mFOLFOX6 plus bevacizumab].
Yokoyama M; Urakawa M; Murakami T; Amano K; Ohsawa T; Okada N; Kumamoto K; Ishibashi K; Ishida H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2241-3. PubMed ID: 22202342
[TBL] [Abstract][Full Text] [Related]
14. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
Seki H; Ozaki T; Shiina M
Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
[TBL] [Abstract][Full Text] [Related]
15. [A successfully resected case of colorectal cancer with multiple liver metastases treated with FOLFIRI after failure of mFOLFOX6].
Fukuda H; Tazawa K; Sawada S; Nagata T; Uotani H; Hirokawa S; Yamagishi F; Tsukada K
Gan To Kagaku Ryoho; 2008 Mar; 35(3):507-9. PubMed ID: 18347406
[TBL] [Abstract][Full Text] [Related]
16. Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency.
Sugimoto M; Yasuda H; Koda K; Yamazaki M; Tezuka T; Takenoue T; Kosugi C; Higuchi R; Yamamoto S; Watayo Y; Yagawa Y; Suzuki M
Hepatogastroenterology; 2007 Sep; 54(78):1684-8. PubMed ID: 18019695
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of conversion chemotherapy for initially unresectable synchronous colorectal liver metastasis.
Baba K; Oshita A; Kohyama M; Inoue S; Kuroo Y; Yamaguchi T; Nakamura H; Sugiyama Y; Tazaki T; Sasaki M; Imamura Y; Daimaru Y; Ohdan H; Nakamitsu A
World J Gastroenterol; 2015 Feb; 21(6):1982-8. PubMed ID: 25684967
[TBL] [Abstract][Full Text] [Related]
18. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
Ducreux M; Ychou M; Laplanche A; Gamelin E; Lasser P; Husseini F; Quenet F; Viret F; Jacob JH; Boige V; Elias D; Delperro JR; Luboinski M;
J Clin Oncol; 2005 Aug; 23(22):4881-7. PubMed ID: 16009952
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic effect of mFOLFOX6 for synchronous unresectable liver metastases from colorectal cancer].
Chikatani K; Ishibashi K; Tajima Y; Hatano S; Amano K; Ishiguro T; Kuwabara K; Sobajima J; Ohsawa T; Okada N; Kumamoto K; Haga N; Iwama T; Ishida H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2211-3. PubMed ID: 22202333
[TBL] [Abstract][Full Text] [Related]
20. Severe liver dysfunction and safe use of 5-fluorouracil leucovorin and oxaliplatin in one patient with metastatic colorectal carcinoma.
Tural D; Akar E; Öztürk MA; Yıldız Ö; Turna H; Serdengeçti S
J Cancer Res Ther; 2014; 10(3):745-8. PubMed ID: 25313774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
